Search

Reading Time: 3 minutesA Little SHYFT Analytics History SHYFT Analytics was founded in 2004 by a team of technology and life sciences experts, including Frank Lane—currently Medidata AI’s vice president of Customer Engagement for Commercial Data Solutions. Over the next 15 years, SHYFT provided commercial data management and insights for over 75 brands across the industry and dozens […]

Article

Reading Time: 2 minutesMedidata Acorn AI’s Ana Fernández Oromendia, PhD spoke on a panel for Harvard’s Precision Medicine 2021 Conference, focusing on race and ethnicity. In particular, the conference looked into how race and ethnicity both inform and bias precision medicine diagnostics and therapeutics. In this panel, Oromendia spoke with Emma Pierson, PhD, Assistant Professor at Cornell and […]

Article

Reading Time: 3 minutesRave Imaging, Medidata’s secure clinical trial imaging management platform, just hit a major milestone. The technology has been used to support more than 1,000 clinical trials globally. Since hitting the market in 2009, Rave Imaging has served to re-engineer clinical trial image management. Built on the Medidata Clinical Cloud, the technology provides unprecedented real-time visibility […]

Article

Reading Time: 3 minutesClinical data transformation is a key process to enable the analysis of clinical trial data. Transformed data powers both single and cross-study analyses. In addition, it also unlocks the ability to use historical trial data to generate an external control group or Synthetic Control Arm (SCA) in new studies—replacing the need to recruit patients into […]

Article

Reading Time: 4 minutes Good drug and device safety is the bedrock of good clinical development, and that means keeping a meticulous catalogue of clinical events. To know whether your therapy or treatment works as intended, you must know with absolute precision how large numbers of individual patients respond to it. But how do you decide with certainty whether […]

Article

Reading Time: 3 minutesClinical endpoint committees (CECs) were first conceived in the 1990s by a pair of academic cardiologists to better manage and vet all of the clinical events data being produced by the increasing volume and complexity of clinical trials.1 Duke University professor of cardiology, Robert Califf, M.D. and Kenneth Mahaffey, M.D., Vice Chair of Clinical Research […]

Article

Reading Time: 3 minutesComplex clinical trial data management challenges demand quality digital solutions. So it’s no surprise that digital processing is increasingly recognized as the most efficient and reliable way to manage clinical endpoint adjudication by committee (CEC). In fact, in 2016, a joint industry-regulatory body that oversees pharmaceutical development known as the The International Council for Harmonisation […]

Article

Reading Time: 2 minutesThis blog was authored by Fiona Maini, Global Compliance and Strategy Principal, and Valeria Orlova, Global Compliance and Strategy Analyst. As decentralized clinical trials (DCTs) are becoming increasingly more abundant, there is still a need for higher transparency in the industry concerning the digital format of clinical data. From the traditionally paper-based conduct of clinical […]

Article

Reading Time: 3 minutesWhen it comes to clinical trials, data is king—so it may come as little surprise that life sciences companies are always looking at ways to incorporate clinical trial technologies that increase the amount of data collected. Wearable sensors in clinical trials, as well as other remote data capture devices, are key parts of gathering more […]

Article

Reading Time: 4 minutes This blog was authored by Fiona Maini, Global Compliance and Strategy Principal at Medidata. The COVID-19 pandemic represented a turning point for healthcare. This situation prompted a rapid shift of resources and services to help maintain and control the virus, as well as a necessity for innovation accelerating the pace of change in the […]

Article

Reading Time: 4 minutesOne top clinical research organization (CRO) says that around 70% of all the clinical trials they conduct involve at least one aspect of a decentralized clinical trial (DCT). And that number may be conservative given that the COVID-19 pandemic has highlighted—and in many cases, necessitated—elements of DCTs and their benefits for conducting clinical trials for […]

Article

Reading Time: 2 minutesTrust. It’s a simple concept that can be hard to define. And too often when life sciences companies talk about trustworthiness, it’s because theirs is in question. Medidata Approaches Trust Differently At Medidata, trust is at the core of every decision we make, because trust is the foundation of every successful relationship—be it personal or […]

Article